AstraZeneca reports 1.55B voting rights at October 31

The reported voting-rights total is the denominator shareholders may use to assess whether an interest or change in interest must be notified under FCA rules.

Available on EDGAR 11/02/2026 - 10:23 AM EST Accepted by SEC EDGAR 11/02/2026 - 10:23 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

AstraZeneca PLC (AZN) reported 1,551,065,237 ordinary shares of US$0.25 with voting rights as of October 31, 2026, and no shares held in treasury. Shareholders may use 1,551,065,237 as the denominator for determining whether they must notify the company of an interest or a change in interest under the Financial Conduct Authority’s Disclosure and Transparency Rules.

Key Figures

Issued ordinary shares with voting rights: 1,551,065,237 shares Total voting rights: 1,551,065,237 Shares held in treasury: 0 shares +1 more

4 metrics

Issued ordinary shares with voting rights 1,551,065,237 shares As of October 31, 2026

Total voting rights 1,551,065,237 As of October 31, 2026

Shares held in treasury 0 shares As of October 31, 2026

Nominal value per ordinary share US$0.25 Issued share capital

Key Terms

issued share capital, total number of voting rights, denominator

3 terms

issued share capital financial

"issued share capital of AstraZeneca PLC"

Issued share capital is the total value or number of a company's shares that have been created and given to investors, employees or others; think of it as the slices of a cake that have already been cut and distributed. It matters to investors because it determines ownership percentages, potential voting power and how future share sales can dilute existing holdings, affecting share value and control.

total number of voting rights regulatory

"total number of voting rights in AstraZeneca PLC"

denominator regulatory

"denominator for the calculations"

The denominator is the number on the bottom of a fraction that shows the total population or base used to calculate a rate, percentage or ratio — for example, the total shares outstanding when calculating earnings per share, or all trial participants when reporting a safety rate. It matters to investors because changing the denominator (by issuing more shares, changing the population measured, or narrowing the base) can make percentages and per‑unit figures look better or worse even if the underlying raw numbers stay the same, much like changing the size of a pizza makes each slice appear larger or smaller.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many voting rights does AstraZeneca (AZN) have?

AstraZeneca had 1,551,065,237 voting rights as of October 31, 2026. This total corresponds to 1,551,065,237 ordinary shares of US$0.25 with voting rights; no shares were held in treasury. Shareholders may use the total as the denominator under the Financial Conduct Authority’s Disclosure and Transparency Rules.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

For the month of November 2026 

Commission File Number: 001-11960

AstraZeneca PLC

1 Francis Crick Avenue

Cambridge Biomedical Campus

Cambridge CB2 0AA

United Kingdom

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F X Form 40-F __

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes __ No X

If “Yes” is marked, indicate below the file number assigned to the Registrant in connection with Rule 12g3-2(b): 82-_____________

AstraZeneca PLC

INDEX TO EXHIBITS

1.Total Voting Rights

2 November 2026

Total Voting Rights

The following notification is made in accordance with the UK Financial Conduct Authority’s Disclosure and Transparency Rule 5.6.1. As at 31 October 2026 the issued share capital of AstraZeneca PLC with voting rights is 1,551,065,237 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,551,065,237.

The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, AstraZeneca PLC under the UK Financial Conduct Authority's Disclosure and Transparency Rules.

AstraZeneca

AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Disease, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca’s innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Social Media @AstraZeneca.

Contacts

For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.

Matthew Bowden

Company Secretary

AstraZeneca PLC

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AstraZeneca PLC

Date: 02 November 2026

By: /s/ Matthew Bowden

Name: Matthew Bowden

Title: Company Secretary